Health Care & Life Sciences » Biotechnology | BioStem Technologies Inc.

BioStem Technologies Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2016
2017
Cash & Short Term Investments
166.30
51.60
Total Accounts Receivable
16.80
18.60
Inventories
93.80
146.60
Other Current Assets
13.10
14.30
Total Current Assets
290.00
231.10
Net Property, Plant & Equipment
1,680.70
1,677.50
Long-Term Note Receivable
10.00
25.50
Intangible Assets
744.90
469.60
Other Assets
22.50
12.00
Total Assets
2,748.00
2,415.70
ST Debt & Current Portion LT Debt
400.00
455.00
Accounts Payable
1,307.40
562.00
Other Current Liabilities
49.60
81.20
Total Current Liabilities
1,756.90
1,098.20
Long-Term Debt
500.00
500.00
Total Liabilities
2,256.90
1,598.20
Common Equity (Total)
495.40
843.10
Total Shareholders' Equity
495.90
843.10
Total Equity
491.10
817.60
Liabilities & Shareholders' Equity
2,748.00
2,415.70
Accumulated Minority Interest
4.80
25.50
Preferred Stock (Carrying Value)
0.50
-

About BioStem Technologies

View Profile
Address
4749 North East, 11th Avenue
Oakland Park Florida 33334
United States
Employees -
Website http://www.biostemtechnologies.com
Updated 07/08/2019
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W.